Moderna Stock Faces Continued Volatility, Analysts Warn
Investors are advised to prepare for further fluctuations in Moderna's stock price, as current valuations appear to rely on highly optimistic future outcomes.
Business & Markets • an hour ago
Moderna's stock price is poised for continued volatility, with analysts cautioning investors to anticipate further sharp movements. Despite recent declines, the company's current market valuation appears to depend on assumptions of significant future successes.
The drugmaker's stock has experienced considerable swings, reflecting uncertainty about its long-term growth prospects beyond its COVID-19 vaccine.
Investors are urged to brace for more unpredictable trading as the market assesses Moderna's pipeline and its ability to replicate its pandemic-era success in other therapeutic areas.